Search

Your search keyword '"Visseren, Flj"' showing total 264 results

Search Constraints

Start Over You searched for: Author "Visseren, Flj" Remove constraint Author: "Visseren, Flj"
264 results on '"Visseren, Flj"'

Search Results

1. Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention

4. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

5. ESC 2021 Guideline on the prevention of cardiovascular disease in clinical practice clinical practice

6. Number of measurement days needed for obtaining a reliable estimate of home blood pressure and hypertension status

7. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data

8. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

9. Adiposity and risk of decline in glomerular filtration rate : Meta-analysis of individual participant data in a global consortium

10. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

11. Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium

12. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.

15. Chronic kidney disease measures and incident peripheral artery disease: A collaborative meta-analysis from the Chronic Kidney Disease Prognosis Consortium

16. Inclisiran in patients with high CV risk and elevated LDL-cholesterol

17. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate

19. Comorbidity in cardiovascular disease: a widespread phenomenon

23. Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk

26. Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort

29. Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease

30. Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

31. Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.

32. Individualized Vascular Disease Prevention in High-Risk Patients

38. Hart- en vaatziekten in Nederland in 2015: Cijfers over heden, verleden en toekomst

41. Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort.

42. Vascular risk of lipid genotype and phenotype in patients with arterial disease

45. Adiposity, adipocytokines & microvesicles in the etiology of vascular disease

46. Adipose tissue and arterial changes in young children

47. Metabolic and Vascular Consequences of Adipose Tissue Dysfunction

48. The effect of physical exercise and resting heart rate on cardiovascular risk

49. Local and systemic effects of visceral and perivascular adipose tissue

50. Hypertension-related organ damage and vascular disease

Catalog

Books, media, physical & digital resources